Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of BGE-175 in Hospitalized Adults With COVID-19

NCT04705597 is registered in ClinicalTrials.gov with BioAge Labs, Inc. as lead sponsor.

NCT NCT04705597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04705597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of BGE-175 in Hospitalized Adults With COVID-19
Lead sponsor
BioAge Labs, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
March 18, 2021
Completion date
May 19, 2022
Enrollment
194 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

covid19